X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs STRIDES SHASUN LTD - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD STRIDES SHASUN LTD ORCHID PHARMA LTD/
STRIDES SHASUN LTD
 
P/E (TTM) x -0.6 14.1 - View Chart
P/BV x 0.5 1.9 24.0% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ORCHID PHARMA LTD   STRIDES SHASUN LTD
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
STRIDES SHASUN LTD
Mar-16
ORCHID PHARMA LTD/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs1941,413 13.7%   
Low Rs35848 4.1%   
Sales per share (Unadj.) Rs276.5353.3 78.3%  
Earnings per share (Unadj.) Rs-79.223.4 -338.7%  
Cash flow per share (Unadj.) Rs-43.541.0 -106.0%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs53.9320.4 16.8%  
Shares outstanding (eoy) m70.4589.35 78.8%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x0.43.2 12.9%   
Avg P/E ratio x-1.448.3 -3.0%  
P/CF ratio (eoy) x-2.627.6 -9.6%  
Price / Book Value ratio x2.13.5 60.2%  
Dividend payout %021.4 0.0%   
Avg Mkt Cap Rs m8,067100,988 8.0%   
No. of employees `0002.84.7 59.7%   
Total wages/salary Rs m2,5274,988 50.7%   
Avg. sales/employee Rs Th6,956.16,730.0 103.4%   
Avg. wages/employee Rs Th902.51,063.6 84.9%   
Avg. net profit/employee Rs Th-1,993.0445.5 -447.3%   
INCOME DATA
Net Sales Rs m19,47731,564 61.7%  
Other income Rs m4071,212 33.6%   
Total revenues Rs m19,88432,776 60.7%   
Gross profit Rs m1,1035,213 21.2%  
Depreciation Rs m2,5191,573 160.2%   
Interest Rs m5,2271,803 289.9%   
Profit before tax Rs m-6,2363,049 -204.5%   
Minority Interest Rs m20127 15.6%   
Prior Period Items Rs m0-27 0.0%   
Extraordinary Inc (Exp) Rs m511-371 -137.8%   
Tax Rs m-125689 -18.2%   
Profit after tax Rs m-5,5802,089 -267.1%  
Gross profit margin %5.716.5 34.3%  
Effective tax rate %2.022.6 8.9%   
Net profit margin %-28.76.6 -432.8%  
BALANCE SHEET DATA
Current assets Rs m11,01435,949 30.6%   
Current liabilities Rs m32,06019,402 165.2%   
Net working cap to sales %-108.152.4 -206.1%  
Current ratio x0.31.9 18.5%  
Inventory Days Days9571 133.8%  
Debtors Days Days34127 26.5%  
Net fixed assets Rs m29,44034,478 85.4%   
Share capital Rs m705894 78.8%   
"Free" reserves Rs m2,04322,601 9.0%   
Net worth Rs m3,80028,632 13.3%   
Long term debt Rs m9,01827,455 32.8%   
Total assets Rs m46,51076,591 60.7%  
Interest coverage x-0.22.7 -7.2%   
Debt to equity ratio x2.41.0 247.5%  
Sales to assets ratio x0.40.4 101.6%   
Return on assets %-0.85.1 -15.0%  
Return on equity %-146.97.3 -2,012.4%  
Return on capital %-3.78.2 -45.7%  
Exports to sales %37.948.1 78.7%   
Imports to sales %22.614.5 156.4%   
Exports (fob) Rs m7,37815,192 48.6%   
Imports (cif) Rs m4,4064,565 96.5%   
Fx inflow Rs m7,51316,612 45.2%   
Fx outflow Rs m5,6495,292 106.7%   
Net fx Rs m1,86511,320 16.5%   
CASH FLOW
From Operations Rs m1,682717 234.7%  
From Investments Rs m-9,860-22,284 44.2%  
From Financial Activity Rs m6,64429,488 22.5%  
Net Cashflow Rs m-1,5358,073 -19.0%  

Share Holding

Indian Promoters % 32.3 27.7 116.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 37.8 12.2%  
FIIs % 3.3 8.6 38.4%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 25.9 213.5%  
Shareholders   84,811 56,241 150.8%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   PIRAMAL ENTERPRISES  NOVARTIS  DR. DATSONS LABS  DR. REDDYS LAB  GSK PHARMA  

Compare ORCHID PHARMA LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Aug 23, 2017 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS